학술논문

Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results
Document Type
Article
Source
In Blood Advances 26 March 2024 8(6):1515-1528
Subject
Myeloid Neoplasia
Clinical Trials and Observations
Language
ISSN
2473-9529